Autumn Glory Partners’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$486K Hold
24,900
0.14% 133
2026
Q1
$479K Buy
24,900
+10,000
+67% +$197K 0.18% 126
2025
Q4
$282K Hold
14,900
0.1% 171
2025
Q3
$278K Hold
14,900
0.11% 160
2025
Q2
$275K Sell
14,900
-30,700
-67% -$545K 0.13% 153
2025
Q1
$797K Buy
45,600
+35,600
+356% +$600K 0.4% 75
2024
Q4
$173K Buy
+10,000
New +$183K 0.09% 170

Other funds holding SBRA

Autumn Glory Partners's SBRA Position: Q2 2026 in Review

Autumn Glory Partners held its Sabra Healthcare REIT (SBRA) position steady in Q2 2026 at 24,900 shares worth $486K. The position accounts for 0.14% of the portfolio, ranked #133.

Autumn Glory Partners first reported a position in SBRA in Q4 2024 and has held it in 7 quarters since. The position peaked at $797K in Q1 2025. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Autumn Glory Partners held 24,900 shares of Sabra Healthcare REIT worth $486K as of Q2 2026.
  • Autumn Glory Partners left its Sabra Healthcare REIT share count unchanged in Q2 2026.
  • Sabra Healthcare REIT made up 0.14% of Autumn Glory Partners's portfolio in Q2 2026, its #133 holding.
  • Autumn Glory Partners first reported a position in Sabra Healthcare REIT in Q4 2024 and has held it in 7 quarters since.
  • Autumn Glory Partners's Sabra Healthcare REIT position peaked at $797K in Q1 2025.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Autumn Glory Partners's 13F filing for Q2 2026, filed 3 Aug 2026.